What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Motexafin gadolinium, Internal medicine, Endocrinology, Cancer research and Longevity are his primary areas of study.
His Motexafin gadolinium research integrates issues from Nuclear medicine, Reactive oxygen species, Magnetic resonance imaging and Texaphyrin.
His studies examine the connections between Internal medicine and genetics, as well as such issues in CD3, with regards to Tyrosine phosphorylation and Signal transduction.
His biological study spans a wide range of topics, including Phenotype, Phosphorylation and Methionine.
Richard A. Miller has researched Cancer research in several fields, including Apoptosis, Protein kinase B, Programmed cell death, Transcriptome and Receptor.
His research integrates issues of Immunosenescence, Natural selection and Transcription factor in his study of Longevity.
His most cited work include:
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy (1052 citations)
- Methionine‐deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF‐I and insulin levels, and increases hepatocyte MIF levels and stress resistance (504 citations)
- Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial (420 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Endocrinology, Cell biology, Immunology and Cancer research.
His research brings together the fields of Oncology and Internal medicine.
As part of the same scientific family, Richard A. Miller usually focuses on Endocrinology, concentrating on Longevity and intersecting with Genetic heterogeneity.
His study looks at the relationship between Cell biology and topics such as T-cell receptor, which overlap with CD3.
Immunology is often connected to Molecular biology in his work.
The Cancer research study combines topics in areas such as Motexafin gadolinium, Apoptosis, Adenosine and Cytotoxicity.
He most often published in these fields:
- Internal medicine (25.24%)
- Endocrinology (22.08%)
- Cell biology (16.72%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (25.24%)
- Endocrinology (22.08%)
- Cancer research (14.20%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Endocrinology, Cancer research, Longevity and Adenosine.
Richard A. Miller merges Internal medicine with Context in his study.
His work in Cancer research tackles topics such as T-cell lymphoma which are related to areas like Antigen.
The concepts of his Longevity study are interwoven with issues in Calorie restriction, Weight gain, Transcriptome and Gene.
His work is dedicated to discovering how Transcriptome, DNA are connected with Cell biology and other disciplines.
His Adenosine research also works with subjects such as
- Tumor microenvironment which is related to area like Receptor,
- Antibody most often made with reference to Immune system,
- Cancer treatment most often made with reference to Adenosine A2A receptor.
Between 2016 and 2021, his most popular works were:
- Using DNA Methylation Profiling to Evaluate Biological Age and Longevity Interventions (149 citations)
- Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions (98 citations)
- A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models (60 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
His primary scientific interests are in Endocrinology, Internal medicine, Longevity, Immune system and Acarbose.
His study brings together the fields of Cancer and Endocrinology.
His Internal medicine research includes elements of Glycine and Downregulation and upregulation.
His Longevity study combines topics in areas such as Calorie restriction, Genome, Gene, Biomarker and CpG site.
His Immune system study combines topics from a wide range of disciplines, such as Periodontitis, Cancer research and Adenosine.
Richard A. Miller combines topics linked to Receptor with his work on Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
